NewKerala.com

CDSCO Cracks Down on Misleading Obesity Drug Ads Targeting Public

India's Central Drugs Standard Control Organization (CDSCO) has issued a strict advisory against the misleading promotion of prescription medications for obesity. The regulator has prohibited any direct or indirect advertisement of such drugs, including GLP-1 receptor agonists, to the general public through any media platform. It warns against promotional activities that exaggerate claims, guarantee weight loss, or undermine the role of lifestyle changes. The advisory mandates that these drugs only be prescribed by registered medical practitioners and requires firms to submit comprehensive safety plans.

Key Points: CDSCO Bans Misleading Ads for Prescription Obesity Drugs

  • Bans indirect ads for obesity drugs
  • Targets misleading digital promotions
  • Requires strict doctor prescriptions
  • Mandates Risk Management Plans
2 min read

CDSCO issues advisory to curb misleading promotion of prescription medications for obesity

India's drug regulator CDSCO issues advisory prohibiting direct or indirect promotion of prescription weight-loss medicines like GLP-1 agonists to the public.

"any direct or indirect advertisement of prescription medicines to the public is strictly prohibited - CDSCO Advisory"

New Delhi, March 11

The Central Drugs Standard Control Organization has issued an advisory to pharmaceutical manufacturers, importers, and marketing authorization holders to ensure strict compliance with the provisions of the Drugs and Cosmetics Act, 1940 and Rules, 1945 in the promotion and marketing of prescription medicines, particularly GLP-1 receptor agonists and similar drugs indicated for obesity and metabolic disorders, the release said.

The advisory highlights concerns regarding certain promotional activities, including disease awareness campaigns and digital outreach, that may indirectly promote prescription-only medicines to the general public.

CDSCO has clarified that such drugs must be prescribed only by Registered Medical Practitioners in accordance with approved indications and conditions of marketing authorisation.The regulator has reiterated that any direct or indirect advertisement of prescription medicines to the public is strictly prohibited, including promotional activities on print, electronic, digital, or social media platforms.

Activities that exaggerate therapeutic claims, guarantee weight-loss outcomes, or undermine the importance of lifestyle modifications such as diet and physical activity will be treated as misleading promotion.

CDSCO has advised all concerned stakeholders to strictly adhere to regulatory and ethical marketing standards. Firms have also been directed to ensure proper prescribing information, maintain consumer grievance mechanisms, and submit comprehensive Risk Management Plans (RMPs) to ensure continued safety monitoring.

The advisory emphasises that obesity is a chronic metabolic condition requiring comprehensive management, including lifestyle interventions, and pharmaceutical therapy should not be projected in a manner that undermines broader public health initiatives.

- ANI

Share this article:

Reader Comments

R
Rohit P
Finally! These companies were acting like they were selling protein powder, not serious medication. My cousin was considering one just from social media hype without consulting a proper doctor. Regulation is key.
A
Aman W
Good move by CDSCO. But I hope the enforcement is as strong as the advisory. We have a tendency for great rules on paper and poor implementation on the ground. Let's see if they actually penalize violators.
S
Sarah B
As someone who manages a chronic condition, I appreciate this. Prescription drugs are not consumer products. The focus should be on proper diagnosis and holistic health, not quick-fix marketing that preys on people's insecurities.
K
Karthik V
Absolutely correct. In India, with our diverse food culture and increasingly sedentary jobs, obesity is a real issue. But the solution isn't a magic shot advertised on Facebook. It's about education, accessible healthy food, and creating spaces for physical activity.
N
Nikhil C
While I agree with the intent, I hope this doesn't stifle legitimate disease awareness. Many people don't know obesity is a medical condition, not just a lifestyle choice. The line between awareness and promotion is thin, but both are needed.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50